Pharmacokinetic Study of OPC-1085EL Ophthalmic Solution in Healthy Male Adult Volunteers

Trial Profile

Pharmacokinetic Study of OPC-1085EL Ophthalmic Solution in Healthy Male Adult Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jun 2016

At a glance

  • Drugs Carteolol/latanoprost (Primary) ; Carteolol; Latanoprost
  • Indications Glaucoma; Ocular hypertension
  • Focus Pharmacokinetics
  • Sponsors Otsuka Pharmaceutical
  • Most Recent Events

    • 12 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrial.gov record.
    • 07 Jul 2014 Planned End Date changed from 1 May 2014 to 1 Oct 2014 as reported by ClinicalTrial.gov.
    • 07 Jul 2014 Planned primary completion date changed from 1 May 2014 to 1 Oct 2014 as reported by ClinicalTrial.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top